Literature DB >> 24583142

SV40 TAg mouse models of cancer.

Emily K Colvin1, Chris Weir2, Rowan J Ikin3, Amanda L Hudson4.   

Abstract

The discovery of a number of viruses with the ability to induce tumours in animals and transform human cells has vastly impacted cancer research. Much of what is known about tumorigenesis today regarding tumour drivers and tumour suppressors has been discovered through experiments using viruses. The SV40 virus has proven extremely successful in generating transgenic models of many human cancer types and this review provides an overview of these models and seeks to give evidence as to their relevance in this modern era of personalised medicine and technological advancements.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Mouse model; SV40; Transgenic

Mesh：

Substances：

Year:  2014        PMID： 24583142     DOI： 10.1016/j.semcdb.2014.02.004

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN： 1084-9521            Impact factor:   7.727


  10 in total

Review 1.  Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction.

Authors:  Agnieszka Toma-Jonik; Natalia Vydra; Patryk Janus; Wiesława Widłak
Journal:  Cell Oncol (Dordr)       Date:  2019-06-10       Impact factor: 6.730

Review 2.  Mouse models of adrenocortical tumors.

Authors:  Kaitlin J Basham; Holly A Hung; Antonio M Lerario; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2015-12-08       Impact factor: 4.102

Review 3.  Human BK Polyomavirus-The Potential for Head and Neck Malignancy and Disease.

Authors:  Raquel Burger-Calderon; Jennifer Webster-Cyriaque
Journal:  Cancers (Basel)       Date:  2015-07-08       Impact factor: 6.639

4.  Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.

Authors:  Cleo Robinson; Ian M Dick; Michael J Wise; Andrew Holloway; Dileepa Diyagama; Bruce W S Robinson; Jenette Creaney; Richard A Lake
Journal:  BMC Cancer       Date:  2015-12-18       Impact factor: 4.430

5.  Defective heat shock factor 1 inhibits the growth of fibrosarcoma derived from simian virus 40/T antigen‑transformed MEF cells.

Authors:  Qiying Jiang; Zhi Zhang; Shulian Li; Zhaoyang Wang; Yuanfang Ma; Yanzhong Hu
Journal:  Mol Med Rep       Date:  2015-09-09       Impact factor: 2.952

Review 6.  Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?

Authors:  Felicia Leccia; Marie Batisse-Lignier; Isabelle Sahut-Barnola; Pierre Val; A-Marie Lefrançois-Martinez; Antoine Martinez
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-15       Impact factor: 5.555

7.  PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression.

Authors:  Mi Kyung Park; Yixin Yao; Weiya Xia; Stephanie Rebecca Setijono; Jae Hwan Kim; Isabelle K Vila; Hui-Hsuan Chiu; Yun Wu; Enrique González Billalabeitia; Min Gyu Lee; Robert G Kalb; Mien-Chie Hung; Pier Paolo Pandolfi; Su Jung Song; Min Sup Song
Journal:  Nat Commun       Date:  2019-02-07       Impact factor: 14.919

8.  Polyomavirus JCPyV infrequently detectable in adenoid cystic carcinoma of the oral cavity and the airways.

Authors:  Hanna Hämetoja; Jaana Hagström; Caj Haglund; Leif Bäck; Antti Mäkitie; Stina Syrjänen
Journal:  Virchows Arch       Date:  2019-07-01       Impact factor: 4.064

Review 9.  Thymic and Postthymic Regulation of Naïve CD4(+) T-Cell Lineage Fates in Humans and Mice Models.

Authors:  José E Belizário; Wesley Brandão; Cristiano Rossato; Jean Pierre Peron
Journal:  Mediators Inflamm       Date:  2016-05-30       Impact factor: 4.711

10.  NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.

Authors:  Rashid Gabbasov; Fang Xiao; Caitlin G Howe; Laura E Bickel; Shane W O'Brien; Daniel Benrubi; Thuy-Vy Do; Yan Zhou; Emmanuelle Nicolas; Kathy Q Cai; Samuel Litwin; Sachiko Seo; Erica A Golemis; Denise C Connolly
Journal:  Oncogene       Date:  2018-05-18       Impact factor: 9.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.